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ABSTRACT : The surgical outcome for 209 early lung cancers was clinically 
evaluated. 
1) Most (93%) of Stage I cancers were composed of pT1N0 and pT2N0 while 6.3 % 
   was pT1N0. 
2) Even in early cancer, nodal involvement and distant metastasis occurred and 
   these related closely to their prognoses. 
3) Reoperation should be indicated for recurrence with a 10 month or more time in-
   terval from the first operation and should be recommended, if possible. 
     Advances in diagnostic technique for lung cancer have been achieved. As a con-
sequence, early lung cancer has become clinically detected and the surgical curability 
has been improved with time. This study was undertaken to evaluate surgical treat-
ment for stage I lung cancer patients.
         PATIENTS 
 During the past five years, 209 Stage I lung 
cancer patients (40.1%) were surgically oper-
ated upon among a total of 521 lung cancer pa-
tients at the same period of time at the First 
Department of Surgery, Nagasaki University 
School of Medicine. It is a reflection of increas-
ing stage I lung cancer patients. 
 According to histologic findings (Table 1), 
adenocarcinoma included 9 6 cases (46.0% ) , 
squamous cell carcinoma 81 (3 8.8 %) , large 
cellcarcinoma 13 cases (6.2% ) and small cell 
carcinoma six cases ( 2. 8 %) respectively. 
According to p-TNM classification, pT 2 N o M o
was 106 cases (50.7%), pT1NoMo 90 (43.0%), 
pTl No Mo 13 (6.3%) respectively. It is indicat-
ed that stage I lung cancer is mostly composed 
of no-nodal involvement. In view of the opera-
tive method, limited operation was applied to 
25 cases, 22 of whom underwent segmentectomy 
and the remainder three received partial resec-
tion. On the contrary, bilobectomy or pneu-
monectomy were used for 25 cases (11.9%). 
 Deaths in the hospital were encountered in 
four cases (1.9%) and postoperative deaths by 
other diseases were in 19 cases (9.0%). It meant 
that postoperative death was associated with 
not only cancer recurrence but also other dis-
eases. 
 Survival rate of stage I lung cancer patients
Table 1. Stage and histological type in primary 
        lung cancer 
      stage I Moo stageII stagelI stagelV total 
sq.c.c 81( 38.8) 21 91 13 206 
ad.c. 96( 46.0) 17 90 19 222 
large 13( 6.2) 5 19 4 41 
small 6( 2.8) 4 13 1 24 
others 13( 6.2) 1 14 0 28 
total 209(100.0) 48 227 37 521
following surgery is satisfactory as compared 
with those of other stages of lung cancer. In 
particular, it was the best in the survival late 
of more than two years. When compared be-
tween la and lb stages which is classified by 
Japan lung cancer society, the survival rate in 
la of more than two years is more satisfactory 
than that in lb. It is suggestive that nodal in-
volvement is a most contributable factor to 
surgical outcome regardless of the size of the 
tumor. Even if the tumor size would be very 
small, when the nodes be involved, recurrence 
would not infrequently occur within two years 
following surgery. 
 Postoperative recurrences in this series were 
seen in the lung, the bone and the brain includ-
ing the intestinal tract (Fig. 1). It implied that 
blood-borne metastasis was much more common 
than local recurrence to the mediastinum.
Wound metastasis is seen in the case with intes-
tinal metastasis, which might be caused by 
dissemination during the laparotomy procedure. 
 Postoperative early death was encountered 
in 1 1 cases. Three who underwent broncho-
plasty were included. However, it was not 
clear as to whether recurrence was associated 
with the surgical technique or not. The recur-
rent locations were on the right in five and on 
the left in seven. One of them existed on the 
both sides. According to histologic findings, 
all cases showed the same histologic pattern 
without vascular invasion to the lymph vessels. 
 The possibility of metastatic invasion was 
suggested and it was compatible with the evi-
dence of the multiple cancers. 
 Of interest is the fact that all were n o pa-
tients. It implies that even early stage lung 
cancer is prone to occur distant metastasis. 
  Reoperation for recurrence was made in 13 
cases. Surgery was performed in 10 cases of the 
lung and each one of the small intestine, the 
brain and the adrenal gland (Fig. 2).
Fig. 2. Prognosis and Interval between first ope-
      ration and reoperation for metastasis
Fig. 1. Sites of recurrence in stage I lung cancer
 Those who underwent reoperation have sur-
vived more than 40 months, indicating the sur-
gical benefit. Surgery for recurrence is benefi-
cial in making the survival period prolonged. 
Reoperation was carried out for adenocarcinoma 
in all but one of squamous cell carcinoma. 
According to histologic differentiation, there 
was no close relationship between histologic 
differentiation and survival period, that is, 
six were well, two moderate, three poorly and 
two alveolar cell types respectively. 
 Of deaths following reoperation, five had
pulmonary metastases of whom one had con-
comitant hepatic and brain metastasis. Pneu-
monitis and cardiac failure were seen in one, 
but not in other surviving four patients. The 
shorter the time interval from the first to the 
second operations, the poorer the surgical 
outcome were. 
 It appeared that the prognosis of reoperation 
for the patients who had a 20 month course 
after the first operation was very satis-
factory, if brain metastasis is absent. 
        DISCUSSION 
 It is generally accepted that criteria of early 
lung cancer are divided into the hilar and the 
peripheral types of lung cancers. In the periph-
eral types of lung cancers. In the peripheral 
type of lung cancer, however, conclusion is not 
drawn by a consensus of researchers as to whe-
ther the diameter of the tumor mass is less 
than 2cm or 1.5cm. 
 On the contrary, it is not clinically practical 
if the criterion should be determined to be less 
than 1cm of the tumor diameter. It is difficult 
for the clinical use, and is not applicable. 
 Clinically early stage of lung cancer includes 
pT1 No , pTl N1, pT2 No according to TNM clas-
sification. Most of early cancer patients in this 
series comprised pT 1 N o and pT 2 N o . The pa-
tients who had a stage of T 1 N 1 were as many 
as 6%. According to histologic findings, adeno-
carcinoma predominated in the early lung can-
cer. It is a reflection that adenocarcinoma may 
well be easily detected on chest x-ray films as 
the peripheral type. On the contrary, squamous 
cell carcinoma was shown in 38.8%. Recently 
carcinoma limited to the mucosal layer can be 
diagnosed by cytology and bronchoscopy, 1) 2) 
and clinical patterns have also become appar-
ent. 2) 3) 4) Concern has been raised regarding 
early detection and treatment of lung cancer. 
It is generally believed that it takes a long pe-
riod with an average of 6. 2 years to develop 
from early cancer to infiltrative one. 5) 
 Koss6) reported that a period of four to six 
years is needed for the cancer tumor to develop 
from occult cancer lesion to clinically detec-
table tumor mass. Since it has a tendency to-
ward multicentric development of the tumors
in their growing course. 7) it is emphaseized 
that accurate examination is required for de-
tecting other lesions and it should be deter-
mined as to whether it is metastatic or second 
tumor. It is reported that the second tumor 
develops in frequency of as many as 3. 8 to 
7.6%.8) s) Criteria of judging a second tumor 
are not certain. One criterion` is that the time 
interval from the first to the second tumors 
should be 30 to 36 months. 10) ;another is that 
each tumor should be separated.91 
 The prognosis for early lung' cancer depends 
on .the positive nodal involvement rather than 
the histologic type or the tumor size. 
 Even in T1 tumor, surgical outcome is affect-
ed by the presence of nodal involvement and 
distant metastasis. Therefore, multidisciplinary 
therapy is necessary in preventing distant meta-
stasis even in early lung cancer, and potent 
chemotherapy, sensitive to the tumor by the 
sensitivity test of the anticancer drugs, should 
be prescribed. 
  Furthermore, reoperation for recurrent cancer 
should be indicated for the patients with a 10 
month or longer period interval from the first 
operation to recurrence.] 1 
 As to the second tumor, there are many re-
ports which are indicating satisfactory or 
worse prognoses. It is evident that the progno-
sis for the second tumor is attributable to the 
disease stages including nodal involvement and 
distant metastasis. The prognoses for brain 
and intestine metastases were very poor, and 
surgery was palliative to alleviate the in-
creased intracranial pressure and obstruction 
of the digestive tract. The surgical outcome for 
pulmonary and adrenal metastases could be 
fair in saving life. Therefore, if feasible in any 
time, surgery for organ metastasis is recom-
mended. 
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